Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

MTU951

Multiple tumor tissue array covering 40 types of all the common benign, malignant and metastatic entities, 40 cases/95 cores
Unstained: $170.00 Add to Cart
H&E (MTU951s*): $170.00 Add to Cart

Microarray Panel:Multiple tumor tissue microarray, 40 types, covering most of the common benign, malignant and metastatic tumors originated from 27 anatomic sites (adrenal gland, bladder, bone, breast, cerebra (brain), rectum, kidney, liver, lung, lymph node, oranasopharynx, ovary, pancreas, prostate, salivary gland, skin, testis, thyroid and uterus endometrium). Majority of the tumors have duplicates or triplicates from different individuals with corresponding uninvolved tissues as controls. Most of the tissues were from surgical resection. Those highlighted by '* were from autopsy
Cores:95
Cases:40
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:4 µm
Quality Control:H&E, IHC anti-Vimentin/Cytokeratin
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112
A Adr Adr Adr Bla Bla Bla Bre Bre Bre Bre Bre Bre
B Bon Bon Bra Bra Bra Bra Bra Bra Eso Eso Eso Eso
C Sto Sto Sto Sto Int Int Int Int Int Int Int Int
D Int Int Int Int Kid Kid Kid Liv Liv Liv Liv Liv
E Lun Lun Lun Lun Lun Lym Lym Lym Lym Hea Hea Hea
F Ova Ova Ova Ova Pan Pan Pro Pro Pro Hea Hea Hea
G Ski Ski Hea Tes Tes Tes Thr Thr Thr Thr Thr Thr
H Ute Ute Ute Ute Ute Ute Liv Lun Lym Ova Lym
Legend: Adr - Adrenal gland, Bla - Bladder, urinary, Bon - Bone, scapula, Bra - Brain, Bre - Breast, Eso - Esophagus, Hea - Head and neck, nasal cavity, Int - Intestine, rectum, Kid - Kidney, Liv - Liver, Lun - Lung, Lym - Lymph node, Ova - Ovary, Pan - Pancreas, Pro - Prostate, Ski - Skin, trunk, Sto - Stomach, Tes - Testis, Thr - Thyroid, Ute - Uterus, endometrium

- Benign tumor, - , - Malignant tumor, - Metastasis, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 F 37 Adrenal gland Normal, hyperplasia Normal
A2 2 M 61 Adrenal gland Adenoma, cortical Benign
A3 3 M 28 Adrenal gland Adrenocortical carcinoma T2N0M0 Malignant
A4 4 M 53 Bladder, urinary Normal Normal
A5 5 F 53 Bladder, urinary Transitional cell carcinoma I~II T1N0M0 Malignant
A6 6 F 65 Bladder, urinary Transitional cell carcinoma I~II T1N0M0 Malignant
A7 7 F 30 Breast Normal Normal
A8 8 F 40 Breast Fibroadenoma Benign
A9 9 F 39 Breast Fibroadenoma Benign
A10 10 F 58 Breast Invasive ductal carcinoma II T2N1M0 Malignant
A11 11 F 53 Breast Invasive ductal carcinoma II T2N0M0 Malignant
A12 12 F 42 Breast Invasive ductal carcinoma II T4N1M0 Malignant
B1 13 M 17 Bone, tibia Osteosarcoma Malignant
B2 14 M 44 Bone, scapula Chondrosarcoma Malignant
B3 15 M 49 Brain, cerebellum Normal* Normal
B4 16 F 65 Brain, cerebellum Meningioma, fibroblastic Benign
B5 17 M 55 Brain, cerebellum Malignant meningioma Malignant
B6 18 M 58 Brain Normal* Normal
B7 19 F 26 Brain Meningioma, fibroblastic Benign
B8 20 M 47 Brain Astrocytoma II Benign
B9 21 M 53 Esophagus Normal Normal
B10 22 F 68 Esophagus Squamous cell carcinoma I T2N0M0 Malignant
B11 23 M 54 Esophagus Squamous cell carcinoma II T3N1M0 Malignant
B12 24 F 61 Esophagus Squamous cell carcinoma III T2N1M0 Malignant
C1 25 M 59 Stomach Normal Normal
C2 26 M 52 Stomach Adenocarcinoma I T2N0M0 Malignant
C3 27 M 66 Stomach Adenocarcinoma II T3N0M0 Malignant
C4 28 M 47 Stomach Adenocarcinoma III T3N2M0 Malignant
C5 29 F 40 Intestine, small intestine Normal Normal
C6 30 F 18 Intestine, small intestine Adenoma Benign
C7 31 F 57 Intestine, small intestine Adenocarcinoma II T2N0M0 Malignant
C8 32 F 27 Intestine, colon Normal Normal
C9 33 M 57 Intestine, colon Adenoma Benign
C10 34 M 56 Intestine, colon Adenocarcinoma I T3N0M0 Malignant
C11 35 M 89 Intestine, colon Adenocarcinoma II T2N0M0 Malignant
C12 36 F 43 Intestine, colon Adenocarcinoma III T3N0M0 Malignant
D1 37 M 61 Intestine, rectum Normal Normal
D2 38 M 40 Intestine, rectum Adenocarcinoma I T3N0M0 Malignant
D3 39 M 38 Intestine, rectum Adenocarcinoma II T3N1M0 Malignant
D4 40 M 50 Intestine, rectum Adenocarcinoma III T3N1M0 Malignant
D5 41 F 51 Kidney Normal cortex Normal
D6 42 M 40 Kidney Clear cell carcinoma T1N0M0 Malignant
D7 43 F 79 Kidney Clear cell carcinoma T1N0M0 Malignant
D8 44 M 43 Liver Normal Normal
D9 45 M 26 Liver Hepatocellular carcinoma I T2N0M0 Malignant
D10 46 M 40 Liver Hepatocellular carcinoma II T2N0M0 Malignant
D11 47 M 53 Liver Hepatocellular carcinoma I T2N0M0 Malignant
D12 48 M 41 Liver Hepatocellular carcinoma III T2N0M0 Malignant
E1 49 M 58 Lung Normal Normal
E2 50 M 59 Lung Squamous cell carcinoma II T2N2M0 Malignant
E3 51 M 62 Lung Squamous cell carcinoma II~III T2N0M0 Malignant
E4 52 M 72 Lung Adenocarcinoma III T2N2M0 Malignant
E5 53 M 19 Lung Small cell carcinoma T3N0M0 Malignant
E6 54 F 39 Lymph node Reactive Inflammatory
E7 55 M 50 Lymph node, neck Lymphoma, Hodgkin lymphoma Malignant
E8 56 M 42 Lymph node, axillary Lymphoma, non-Hodgkin B-cell lymphoma Malignant
E9 57 M 51 Lymph node, neck Lymphoma, anaplastic large cell lymphoma Malignant
E10 58 F 48 Head and neck, oral cavity, hard palate Adenocarcinoma III~IV Malignant
E11 59 M 56 Head and neck, oral cavity, tongue Squamous cell carcinoma II T2N0M0 Malignant
E12 60 F 48 Head and neck, nasopharynx Nasopharyngeal carcinoma, NPC III T2N0M0 Malignant
F1 61 F 45 Ovary Normal Normal
F2 62 F 55 Ovary Granulosa cell tumor Benign
F3 63 F 45 Ovary Adenocarcinoma III T2N0M0 Malignant
F4 64 F 49 Ovary Endometrioid adenocarcinoma III T1N0M0 Malignant
F5 65 M 35 Pancreas Normal Normal
F6 66 F 49 Pancreas Adenocarcinoma II T3N1M1 Malignant
F7 67 M 65 Prostate Normal, hyperplasia Normal
F8 68 M 60 Prostate Adenocarcinoma II T2N0M0 Malignant
F9 69 M 47 Prostate Adenocarcinoma III T3N0M0 Malignant
F10 70 M 38 Head and neck, salivary gland Normal Normal
F11 71 F 28 Head and neck, salivary gland, parotid Pleomorphic adenoma Benign
F12 72 F 38 Head and neck, salivary gland Adenoid cystic carcinoma I~II T1N0M0 Malignant
G1 73 M 50 Skin Normal Normal
G2 74 M 67 Skin, trunk Squamous cell carcinoma II T2N0M0 Malignant
G3 75 M 53 Head and neck, nasal cavity Melanoma Malignant
G4 76 M 77 Testis Normal Normal
G5 77 M 30 Testis Seminoma Malignant
G6 78 M 28 Testis Seminoma Malignant
G7 79 F 62 Thyroid Normal Normal
G8 80 F 47 Thyroid Adenoma Benign
G9 81 F 27 Thyroid Adenoma Benign
G10 82 F 66 Thyroid Adenoma Benign
G11 83 M 16 Thyroid Follicular carcinoma T3N1M0 Malignant
G12 84 M 34 Thyroid Follicular papillary adenocarcinoma T2N1M0 Malignant
H1 85 F 41 Uterus, cervix Normal Normal
H2 86 F 63 Uterus, cervix Squamous cell carcinoma III T1N0M0 Malignant
H3 87 F 57 Uterus, cervix Squamous cell carcinoma III T1N1M0 Malignant
H4 88 F 50 Uterus, endometrium Normal Normal
H5 89 F 48 Uterus, endometrium Adenocarcinoma I~II T2N0M0 Malignant
H6 90 F 53 Uterus, endometrium Adenocarcinoma II~III T1N1M0 Malignant
H7 91 M 60 Liver Metastatic colon adenocarcinoma Metastasis
H8 92 M 69 Lung Metastatic cancers, from gastrointestional site? Metastasis
H9 93 F 34 Lymph node Metastatic breast invasive ductal carcinoma Metastasis
H10 94 F 40 Ovary Metastatic colon signet ring cell carcinoma Metastasis
H11 95 M 51 Lymph node Metastatic esophagus squamous cell carcinoma Metastasis


† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Sorry, this tissue array cannot be compared to find overlapping cases.
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal